In addition, increased pancreatic insulin secretion drives alpelisib resistance in murine mammary tumor models which is overcome by dietary and pharmacological approaches that reduce insulin signaling and restore alpelisib sensitivity [63]. This evidence concerns the gene INS and breast cancer.